Leading report on the molecular prevalence of emerging pathogens Hepatozoon sp. and Lankesterella sp. in the blood samples of seven wild lizard species

一份关于七种野生蜥蜴血液样本中新发病原体肝孢子虫属(Hepatozoon sp.)和兰氏孢子虫属(Lankesterella sp.)分子流行情况的权威报告

阅读:2

Abstract

Despite of having rich reptilian fauna, the wild lizards from Pakistan remained unexplored for the presence of blood borne parasites. The present study was designed to report the molecular epidemiology and phylogenetic evaluation of various blood borne pathogens (Hepatozoon sp., Schellackia spp., Toxoplasma gondii, Plasmodium spp., Haemoproteus spp. and Leucocytozoon spp.) in blood samples of wild lizards (N = 84), trapped during March 2022 till June 2023 from district Karak and Dir in Khyber Pakhtunkhwa (Pakistan). Seven lizard species were identified during present study. Our results revealed that 11 out of 84 (13%) lizards were Haemogregarines infected. Infected lizards included Laudakia (L.) tuberculata (1/4, 25% prevalence), L. pakistanica (3/15, 20%) and L. agrorensis (7/53, 13%). DNA sequencing and BLAST analysis confirmed the presence of Hepatozoon sp. and Lankesterella sp. While the lizards were negative for the remaining screened pathogens. Phylogenetic analysis of both pathogens revealed genetic diversity among the Pakistani isolates and they clustered with isolates detected in reptiles, birds and rodents from different countries. For L. tuberculata, Haemogregarines prevalence significantly varied between the sample collection sites. In conclusion, this is the first report from Pakistan documenting a relatively higher Haemogregarines infection rate in wild Pakistani lizards. Further, comprehensive and large-scale studies must be conducted in unexplored geo-climatic regions of Pakistan to report the actual prevalence of Haemogregarines among the wild lizards as well as in other wildlife species. These findings will add to our knowledge regarding the genetic diversity and the interactions of these parasites with their hosts that will lead towards parasite control.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。